Alfuzosin is used for: Benign prostatic hyperplasia (BPH).
Recorded in the NepalDoc medicine catalog for Alfuzosin.
Alfuzosin hydrochloride extended-release tablets, USP are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Important.
From the U.S. FDA-approved label for Alfuzosin. Full label: DailyMed.
Alfuzosin hydrochloride extended-release tablets, USP are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Important.
From the U.S. FDA-approved label for Alfuzosin. Full label: DailyMed.
The recommended dosage is one 10 mg alfuzosin hydrochloride extended-release tablet once daily. The extent of absorption of alfuzosin is 50% lower under fasting conditions. Therefore, alfuzosin hydrochloride extended-release tablets should be taken with food and with the same meal each day.
Directions from the U.S. FDA-approved label for Alfuzosin — your doctor or pharmacist may advise differently.
Alfuzosin hydrochloride extended-release tablets are contraindicated for use: in patients with moderate or severe hepatic impairment (Childs-Pugh categories B and C), since alfuzosin blood levels are increased in these patients. with potent CYP3A4 inhibitors such as ketoconazole, itraconazole, and ritonavir, since alfuzosin blood levels are increased.
Excerpt from the U.S. FDA-approved label for Alfuzosin. Talk to a pharmacist or doctor before use.
Postural hypotension/syncope: Care should be taken in patients with symptomatic hypotension or who have had a hypotensive response to other medications or are concomitantly treated with antihypertensive medication or nitrates Use with caution in patients with severe renal impairment (creatinine clearance <30 mL/min) Use with caution in patients with mild hepatic impairment Should not be used in combination with other alpha adrenergic antagonists Prostate carcinoma should be ruled out prior to treatment Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery may require modifications to the surgical…
Warnings and precautions excerpt from the U.S. FDA-approved label for Alfuzosin — not a complete list. Talk to a pharmacist or doctor before use.
Most common adverse reactions in clinical studies (incidence ≥2% and at a higher incidence than placebo): dizziness, upper respiratory tract infection, headache, fatigue. To report SUSPECTED ADVERSE REACTIONS, contact Apotex Corp.
Excerpt from the U.S. FDA-approved label for Alfuzosin — not a complete list. Talk to a pharmacist or doctor about side effects.
4 brands · 4 makers in the NepalDoc catalog — see the full Alfuzosin guide →
Store at 20°C to 25°C (68°F to 77°F); Protect from light and moisture. Keep alfuzosin hydrochloride extended-release tablets, USP out of reach of children.
Storage information from the U.S. FDA-approved label for Alfuzosin.
What is Alzin?
Alzin 10mg Tablet is a Alfuzosin medicine made by Quest Pharmaceuticals Pvt. Ltd. It comes as 10mg Tablet.
What is Alzin used for?
Alfuzosin is used for Benign prostatic hyperplasia (BPH).
What is the generic name of Alzin?
The generic name of Alzin is Alfuzosin.
Which brands of Alfuzosin are available in Nepal?
4 brands of Alfuzosin are listed in the NepalDoc catalog, from 4 makers — including Alfoo 10mg Er Tablet, Fuzon 10mg Tablet, Z Flo SR 10mg Tablet.
What are the side effects of Alfuzosin?
Most common adverse reactions in clinical studies (incidence ≥2% and at a higher incidence than placebo): dizziness, upper respiratory tract infection, headache, fatigue. To report SUSPECTED ADVERSE REACTIONS, contact Apotex Corp.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
